Baricitinib in the treatment of adults with pyoderma gangrenosum: An open-label pilot trial
J Invest Dermatol
.
2026 Jun;146(6):1684-1687.e6.
doi: 10.1016/j.jid.2026.01.016.
Epub 2026 Feb 2.
Authors
Morgan Vague
1
,
Sharon I Choe
2
,
Shannon K Throckmorton
1
,
Alexandra Shinde
1
,
Alex G Ortega-Loayza
3
Affiliations
1
Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
2
Providence Portland Medical Center, Portland, Oregon, USA.
3
Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA. Electronic address: ortegalo@ohsu.edu.
PMID:
41638422
DOI:
10.1016/j.jid.2026.01.016
No abstract available
Keywords:
Dermatologic treatments; Jak inhibitor; Open-label study; Pyoderma gangrenosum; Ulcer.